Gabitril Potential In Anxiety Aided By Positive Side Effect Profile – Cephalon
Executive Summary
Cephalon hopes to market the anti-epileptic Gabitril (tiagabine) for generalized anxiety disorder by 2006 based on a favorable side effect profile
You may also be interested in...
Cephalon Marketing Under Investigation By Philadelphia U.S. Attorney
The Philadelphia U.S. Attorney's investigation into Cephalon's marketing practices covers the entire commercial life of Provigil
Cephalon Marketing Under Investigation By Philadelphia U.S. Attorney
The Philadelphia U.S. Attorney's investigation into Cephalon's marketing practices covers the entire commercial life of Provigil
Cephalon Provigil Has 28% Awareness Among Primary Care Physicians
Cephalon will step up its efforts to target primary care physicians in an effort to raise awareness about the sleep disorder agent Provigil (modafinil)